Literature DB >> 6951181

Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.

J J Skehel, P M Bayley, E B Brown, S R Martin, M D Waterfield, J M White, I A Wilson, D C Wiley.   

Abstract

A conformational change in the hemagglutinin glycoprotein of influenza virus has been observed to occur to pH values corresponding to those optimal for the membrane fusion activity of the virus. CD, electron microscopic, and sedimentation analyses show that, in the pH range 5.2-4.9, bromelain-solubilized hemagglutinin (BHA) aggregates as protein-protein rosettes and acquires the ability to bind both lipid vesicles and nonionic detergent. Trypsin treatment of BHA in the pH 5.0-induced conformation indicates that aggregation is a property of the BHA2 component and that the conformation change also involves BHA1. The implications of these observations for the role of the glycoprotein in membrane fusion are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6951181      PMCID: PMC345880          DOI: 10.1073/pnas.79.4.968

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide.

Authors:  S G Lazarowitz; P W Choppin
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  The size and detergent binding of membrane proteins.

Authors:  S Clarke
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

3.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

4.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

5.  Future influenza vaccines and the use of genetic recombinants.

Authors:  E D Kilbourne
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  The synthesis of phosphoglycerides and some biochemical applications.

Authors:  L L van Deenen; G H de Haas
Journal:  Adv Lipid Res       Date:  1964

8.  Crystalline antigen from the influenza virus envelope.

Authors:  C M Brand; J J Skehel
Journal:  Nat New Biol       Date:  1972-08-02

9.  The polypeptide composition of influenza A viruses.

Authors:  J J Skehel; G C Schild
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

10.  Studies on the primary structure of the influenza virus hemagglutinin.

Authors:  J J Skehel; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

View more
  263 in total

1.  N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil.

Authors:  J Chen; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

3.  Investigation of pathways for the low-pH conformational transition in influenza hemagglutinin.

Authors:  M Madhusoodanan; Themis Lazaridis
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

4.  Formation and characterization of the trimeric form of the fusion protein of Semliki Forest Virus.

Authors:  D L Gibbons; A Ahn; P K Chatterjee; M Kielian
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Residues of the human metapneumovirus fusion (F) protein critical for its strain-related fusion phenotype: implications for the virus replication cycle.

Authors:  Vicente Mas; Sander Herfst; Albert D M E Osterhaus; Ron A M Fouchier; José A Melero
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

6.  Membrane fusion mediated by coiled coils: a hypothesis.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

7.  Role of the mutation Q252R in activating membrane fusion in the murine leukemia virus surface envelope protein.

Authors:  Chi-Wei Lu; Monica J Roth
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.

Authors:  Shaguna Seth; Annelet Vincent; R W Compans
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.

Authors:  Cong Chen; Liguo Liu; Yan Xiao; Sheng Cui; Jianmin Wang; Qi Jin
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

10.  Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin.

Authors:  D A Steinhauer; S A Wharton; J J Skehel; D C Wiley
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.